U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Global Medical Head - Integrated Evidence Generation

Biology & BiotechConfirmed live in the last 24 hours
Full-timeBrussels, BelgiumNo salary listed

About the Job

Requirements

  • Minimum 5–7 years of pharmaceutical or biotechnology experience, including product launch and Medical Affairs, Market Access, or Clinical Development experience.
  • Demonstrated regional or global experience delivering integrated evidence-generation strategy, planning, and execution to produce robust evidence that maximizes an asset’s long-term value to patients.
  • Strong data interpretation and impactful communication skills for internal and external stakeholders; broad understanding of robust data-generation methodologies; and experience with real-world evidence and observational study planning and execution.
  • Experience establishing successful external stakeholder interactions and collaborations as part of medical strategy execution.
  • Strong strategic and business acumen, anticipation of industry trends, and ability to critically analyze complex data.
  • Mastery of therapeutic-area and asset knowledge, with the ability to translate science into clinical patient value and business value.
  • Demonstrated experience and knowledge in clinical and real-world evidence study development and management, and a sound understanding of statistical processes and analysis.
  • Ability to lead with executive presence, emotional intelligence, integrity, business acumen, humility, respect, transparency, and a positive influence on performance excellence.
  • Strong communication skills and ability to articulate complex subjects clearly, with ease and executive presence, including storytelling skills.
  • Strong interpersonal and relationship-building skills, with ability to establish trust and partnership collaboration with cross-functional leadership, internal colleagues, and external collaborators.
  • Digital and AI fluency, including ability to identify and leverage digital technologies, data, and AI-enabled solutions to enhance evidence generation, decision-making, and organizational impact.
  • Adaptability and comfort working with complexity in a fluid environment.

Responsibilities

  • Provide the Asset (Medical Community) Team with a strategic overview of asset activities, including gaps, priorities, tactics, delivery, and expected impact.
  • Develop the asset evidence-generation strategy and ensure timely development and maintenance of the plan in alignment with the asset strategy to maximize impact.
  • Work with the Product Global Medical Head and internal and external stakeholders to understand evidence needs, derive evidence-generation priorities, and identify partnership opportunities.
  • Facilitate cross-functional planning and alignment.
  • Communicate key decisions to relevant stakeholders.
  • Develop the asset budget to execute the plan.
  • Regularly revise and update evidence-generation strategies based on newly available knowledge.
  • Ensure studies in the plan align with strategy and represent the best investment for impact.
  • Lead ISEG project proposal approvals for studies entering the plan.
  • Ensure timely delivery of the plan in support of the asset strategy.
  • Oversee execution to deliver relevant, robust evidence on time.
  • Enhance and track performance and progress through management and monitoring of key metrics and incentives (KPIs).
  • Lead prioritization and strategic planning of post hoc analyses and be accountable for their timely delivery.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs